课题基金 / 基金详情

Expanding Multilevel Multicomponent Mentorship in Kidney Disease Research

Expanding Multilevel Multicomponent Mentorship in Kidney Disease Research
扩大肾脏疾病研究中的多层次多成分指导
批准号:
10797774
负责人:
Kerri Cavanaugh
金额:
$14.05万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-30 至 2028-08-31

项目摘要

项目成果

Kerri Cavanaugh的其他基金

相似基金

相关文献

中文摘要
翻译
肾脏疾病影响全球近三分之一的成年人,并与显著的发病率和 mortality.在过去的三十年里,人们对肾脏的认识有了巨大的进步。 疾病机制,最近导致了新的治疗方法,包括医疗保健提供策略, 加强健康信息的提供,促进成功的自我保健,但生活质量以及 存活率仍然很低,特别是对于那些患有晚期肾病包括肾衰竭的人。 重要的是,NIH/NIDDK已经投资,以确保患者合作伙伴是不可或缺的过程, 优先考虑并进行研究。同样,NIH/NIDDK正在进一步投资,以确保学术 研究人员队伍也是多样化和具有代表性的。这是整个肾脏疾病谱的关键目标 疾病研究包括基础科学、临床和转化研究以及政策研究。卡瓦诺医生是 在肾脏疾病临床试验、健康素养及其影响、形成性研究 阐明并将利益相关者的观点纳入研究和社区参与。她的目标是 利用K26 NIDDK研究者奖的支持来支持早期职业研究人员的指导 从不同的背景,专注于培养下一代科学家带来变革 肾脏疾病研究的进展。候选人的近期和长期职业目标是 研究教师发展的领导者直接符合NIH K26奖的目标,提供 支持获奖者有受保护的时间专门从事辅导培训和对文化敏感的辅导, 博士后研究生。具体来说,这个奖项将使她专注于多层次的发展, 辅导计划,以促进新兴的早期调查人员的职业发展。该奖项将提供 保护候选人的时间,专门用于执行严格的研究,作为主要的, 协作、宣传和网络导师,并发展研究中的导师技能。她的目标是 招募和指导博士后研究员和初级教师在肾脏成功的临床研究生涯 疾病,并支持她目前的学员的职业发展。她将通过以下方式实现这一目标: 利用她的研究计划资源以及强大的机构,区域和国家资源。 目标包括:(a)继续开展有影响力的研究,为学员扩大机会;(B)发展和 部署一个新的文化定制的心理和工具宣传肾病研究 (c)获得由专家咨询委员会提供的指导技能培训;以及(d) 执行招聘计划,以识别和吸引来自不同背景的学员。完成 这些目标将促进来自不同背景的肾病科学家的职业发展, 多样化和发展未来的教师队伍,致力于了解和消除肾脏疾病。
英文摘要
Kidney disease affects nearly one in three adults worldwide and is associated with significant morbidity and mortality. Throughout the last three decades there has been tremendous progress in understanding kidney disease mechanisms that have led recently to new therapies including healthcare delivery strategies to enhance delivery of health information and promote successful self-care, however quality of life as well as survival remains poor especially for those living with advanced kidney disease including kidney failure. Importantly the NIH/NIDDK has invested in ensuring that patient partners are integral to the process of prioritizing as well as carrying out research. Similarly, NIH/NIDDK is further investing in ensuring the academic research workforce is also diverse and representative. This is a critical objective across the spectrum of kidney disease research including basic science, clinical and translational, and policy research. Dr. Cavanaugh is a well recognized expert in kidney disease clinical trials, health literacy and its implications, formative research to elucidate and integrate stakeholder perspectives into research and community engagement. Her objective is to use the support of the K26 NIDDK Investigator Award to Support Mentoring of Early Career Researchers from Diverse Backgrounds to focus on training the next generation of scientists to bring transformative advancements in kidney disease research. The candidate’s immediate and long-term career objectives to be a leader in research faculty development are directly in line with the goals of the NIH K26 award, to provide support for protected time for awardees to devote to mentoring training and culturally-sensitive mentoring for post-doctoral students. Specifically, this award will allow her to focus on the development of a multi-level mentoring program to facilitate the career development of emerging early investigators. This award will provide protected time for the candidate to devote specifically to executing rigorous research, serving as a primary, collaborative, advocacy and network mentor, and to developing mentoring skills in research. Her objective is to recruit and mentor post-doctoral fellows and junior faculty for successful clinical research careers in kidney disease and to support the career advancement of her current trainees. She will accomplish this objective by leveraging her research program resources as well as the robust institutional, regional and national resources. The aims include (a) continued impactful research to expand opportunities for mentees; (b) development and deployment of a novel culturally tailored psychological and instrumental advocacy kidney disease research mentor program; (c) acquisition of mentoring skills training informed by an expert advisory committee; and (d) execution of recruitment programs to identify and engage mentees from diverse backgrounds. Completion of these aims will enhance the career advancement of kidney disease scientists from diverse backgrounds to diversify and grow the future workforce of faculty dedicated to understanding and eliminating kidney disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
Vanderbilt-West Virginia (VWV) Collaborative: A HOPE Consortium Clinical Center
GUARDD-US Additional Recruitment
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
海外基金